Results

Total Results: 1,494 records

Showing results for "harms".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_executive.pdf
    April 01, 2013 - potential harms related to treatment? … Program 2 Task Force recommendation concluded that the potential benefits do not outweigh the harms … .9 However, the balance of benefits and harms of tPSA screening remains controversial.9,10 In 1999 … ) and long-term (e.g., mortality, morbidity, function, quality of life, harms) outcomes. … For all other comparators (Table A), and all other intermediate (impact on decisionmaking, harms of
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_surveillance.pdf
    July 01, 2012 - In women with a palpable for nonpalpable breast abnormality, what are the harms associated with different … did not identify a statistically significant effect of the following factors on the accuracy or harms … the persons performing the biopsies to explore the effect of such factors on the accuracy or harms … Lesions, July 2012 re-assessment Author, Year Country Type of Biopsy Lesions Accuracy results Harms … In women with a palpable for nonpalpable breast abnormality, what are the harms associated with different
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-disposition-comments.pdf
    January 01, 2020 - Could this be stated specifically rather than in general as harms. … Are there other possible harms? Financial burden on families? … We have clarified this in the methods; ”harms” differ by KQ. … However, the rest of the report assesses only maternal harms and does not consider harms to infants … The eligibility criteria makes clear the intended population and harms.
  4. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/assessing-the-risk-of-bias-in-systematic-reviews-of-health-care-interventions-01.pdf
    May 01, 2005 - The prespecification of 13 particular harms, however, may not be possible for all topics; in … Assessing the Risk of Bias for Harms Although harms are almost always included as an outcome in intervention … Harms are defined as the “totality of possible adverse consequences of any intervention, therapy or … the harms and benefits of the treatment. … Better reporting of harms in randomized trials: an extension of the CONSORT statement.
  5. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-maternal-health-grand-rounds-slides.pptx
    January 01, 2023 - 6/13/2023 Key Questions Key Question 1 What are the effectiveness, comparative effectiveness, and harms … Key Question 2 What are the effectiveness, comparative effectiveness, and harms of pharmacological treatments … Key Question 3 What are the comparative effectiveness and harms of alternative magnesium sulfate (MgSO4 … Are there harms associated with the concomitant use of particular antihypertensive medications during … pressure monitoring 54 Key Question 1: What are the effectiveness, comparative effectiveness and harms
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-252-infantile-epilepsies-disposition-comments.pdf
    October 25, 2022 - We changed "However, treating seizures may cause adverse effects and harms that may also contribute … For dietary risks, we re-examined the diet studies for possible reporting of harms, and found a total … We have added to the discussion under harms: "We note that the long-term potential harms of pharmacological … Many parents are anxious to know about these long-term harms, particularly regarding neurocognitive … Regarding the resolution of eye problems, we had not meant to imply that ALL harms of vigabatrin are
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ankyloglossia_disposition-comments.pdf
    May 04, 2015 - Scope of Review, 31 of 274, line 17: The review addresses reported harms, not harms. … We have added a statement about the likelihood of underreporting of harms to the Discussion. … Few studies described what specific methods they used to collect harms data.” … Appendix G documents these studies and the reported harms. … Harms are minimal and rare; the most commonly reported harm is self-limited bleeding.
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
    December 30, 2015 - enabling us to assess harms across the body of evidence. … Our systematic review assessed many harms outcomes. … We assessed harms reported in the original research. … , enabling us to assess harms across the body of evidence. … data on harms and withdrawals be better documented.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antenatal-care.pdf
    January 01, 2020 - The potential benefits and harms or concerns related to telemedicine, as opposed to in-person care, … Key Questions and Eligibility Criteria Key Questions KQ 1: What are the benefits and harms of different … e.g., portal/phone messages) • Provider outcomes: o Provider satisfaction with antenatal care • HarmsHarms: overdiagnosis, delayed diagnoses, harms to marginalized groups/equity outcomes. … We expect to primarily rely on reported within-study differences in effects (or harms).
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_disposition-comments.pdf
    July 08, 2014 - I would worry that if someone were quoting the child harms summary by itself, it wouldn’t be as clear … Modified sentence to focus on other harms of maternal depression. … Modified sentence to focus on other harms of maternal depression. … These studies contributed to the evidence on potential harms with treatment during pregnancy.” … The signals noted here are serious harms found in the indirect evidence.
  11. S5 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s5.pdf
    October 01, 2007 - has drawn significant attention to the need for efficient ways to monitor the potential benefits and harms … This focus is equivalent to finding the balance between benefits and harms for health care services, … to integrate clinical trials with other study designs are especially knotty.3 Reporting benefits and harms … Such harms may not appear in RCTs done in preparation for licensure applications; they may not even arise … Improving depiction of benefits and harms: analyses of studies of well-known therapeutics and review
  12. MEDLINE Searches (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
    March 01, 2009 - Harms§ 3. … • No harms results. … §Harms outcomes are defined by key question 2 and may include but are not limited to: • Thromboembolic … Timing of Outcomes Measurement: • Follow-up too short to detect important benefits or harms. … Evidence Table for Studies of Harms Appendix D-2.
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/mrsa-screening_research.pdf
    June 01, 2013 - MRSA).1 The objective of the CER was to synthesize comparative studies that examined the benefits or harms … comparative effectiveness of MRSA screening on MRSA acquisition, infection, morbidity, mortality, harms … Practice Center (BCBSA TEC EPC) was to synthesize comparative studies that examined the benefits or harms … comparative effectiveness of MRSA screening on MRSA acquisition, infection, morbidity, mortality, harms … • Harms of screening must be clearly delineated.
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-272-genitourinary-syndrome-disposition-comments.pdf
    July 31, 2024 - This was our intention, so we reorganized the effectiveness and harms findings (i.e., KQ2 and 3) to … We did not identify any trials assessing the potential benefits and harms of screening for GSM and … I agree that sample size was not large enough, nor was duration of study long enough to determine harms
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
    December 31, 2013 - extension of an RCT over 24 weeks in duration and investigates clinical outcomes, SAEs, and/or harms … • FDA reports on SAEs and/or harms • Qualitative studies • Publications with no original data … We will also assess for serious and rare harms by including and reviewing harms reports from the FDA … We will report benefits and harms for subgroups of interest including age groups, race, ethnicity, and … Systematic review: comparative effectiveness and harms of combination therapy  and monotherapy  for
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/genitourinary-symptoms-protocol_0.pdf
    July 10, 2023 - Randomized trials are short term, with little long-term efficacy, adherence, or harms data. … Panel, we have drafted the following key questions: • Key Question 1: What is the effectiveness and harms … • Key Question 3: What are the harms (and comparative harms) of hormonal, non- hormonal, and energy-based … Usual care, or different type or level of surveillance Outcomes KQ1: Diagnosis of GSM, potential harms … , results will be organized by treatment comparison, and then by targeted treatment outcome and harms
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-vibration-therapy_disposition-comments.pdf
    November 15, 2011 - brief overview of vibration therapy, including the current understanding of theoretical benefits and harms … brief overview of vibration therapy, including the current understanding of theoretical benefits and harms … brief overview of vibration therapy, including the current understanding of theoretical benefits and harms … brief overview of vibration therapy, including the current understanding of theoretical benefits and harms … brief overview of vibration therapy, including the current understanding of theoretical benefits and harms
  18. effectivehealthcare.ahrq.gov/sites/default/files/presentation.ppt
    August 01, 2009 - hierarchy of outcomes may reflect higher to lower acuity or target outcomes followed by collateral ones; harms … of included studies Examples: summary tables for randomized controlled trials, prevalence studies, harms … Example: Presentation of Harms Data Summary tables can be specialized for different subgroups of the … Example: Presentation of Harms Data Presentation of harms data can be challenging. … This example table presents the range of proportions of individuals experiencing a given set of harms
  19. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
    September 01, 2011 - trial data. 3 This comparative effectiveness review summarizes the evidence on the benefits and harms … strength of evidence and brief conclusions, based on this review, of the comparative benefits and harms … Summary of the evidence on comparative effectiveness and harms of DMARDs for childhood JIA Strength … Summary of the evidence on comparative effectiveness and harms of DMARDs for childhood JIA (continued … Summary of the evidence on comparative effectiveness and harms of DMARDs for childhood JIA (continued
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholder-engagement_research.pdf
    September 01, 2011 - Summary of Primary Prevention Trials–Harms .......................................................... … After reviewing a variety of table and graphical formats for presenting data on benefits and harms, … more effectively represent complex material and what might be concluded regarding the benefits and harms … Summary of primary prevention trials–harms Number of Events Increased With Medications and Strength … • What type of evidence is necessary to establish the relative benefits and harms of PBT?

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: